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SCA1
SCA2
SCA7The relative frequency of different autosomal dominant cerebellar ataxias, commonly referred to as spinocer-
ebellar ataxias (SCAs), varies considerably among populations of different ethnic origin. No data exist at pre-
sent on the frequency of different SCAs in the Greek population. In the present study we investigated the
presence of triplet repeat expansion SCAs (SCA1, SCA2, SCA3, SCA6, SCA7, SCA8, SCA12, SCA17 and DRPLA)
in a cohort of 83 Greek patients with slowly progressive cerebellar ataxia. Twenty patients came from auto-
somal dominant (AD) pedigrees, seven displayed recessive or unclear inheritance and 56 were sporadic. We
found four patients with pathological SCA expansions, all from AD pedigrees. Two patients had SCA1, one
SCA2 and one SCA7 (10.0, 5.0 and 5.0% of the AD group, respectively). The clinical features of these patients
were within the expected spectrum. In total, a pathological expansion was detected in 20% of patients from
AD pedigrees. Interestingly, no cases of SCA3 or SCA6 were detected in the AD group. No expansions were
found in other familial cases or in sporadic patients. Overall, no cases of SCA3, SCA6, SCA12, SCA17 or
DRPLA were identiﬁed in the Greek population. In conclusion, SCA1, SCA2 and SCA7 are present in Greek pa-
tients with AD cerebellar ataxia in frequencies similar to those observed in other populations. SCA3 and SCA6
appear however to be rare in Greece. The genetic cause for the majority of AD ataxias remains to be identiﬁed.
© 2012 Elsevier B.V. Open access under CC BY license.1. Introduction
The autosomal dominant cerebellar ataxias (ADCAs) are a group of
clinically and genetically heterogeneous inherited disorders charac-
terised by progressive cerebellar ataxia often associated with addi-
tional neurological features, such as pyramidal and extrapyramidal
signs, ophthalmoplegia, cognitive impairment, peripheral neuropathy
and optic atrophy [1]. They are referred to in the genetic literature as
‘spinocerebellar ataxias’ (SCAs) and are assigned ascending numerals
chronologically [2]. At present over 35 genetically distinct SCAs have
been identiﬁed [3].
The overall prevalence of ADCAs in European populations is 1 to 3
per 100,000 [2]. The relative frequency of different SCAs varies signif-
icantly according to ethnic origin, partly due to founder effects [4].
The commonest SCAs in most populations are SCA1, SCA2, SCA3,
SCA6 and SCA7, all caused by expanded triplet repeats. Triplet expan-
sions also cause the less common SCA8, SCA12, SCA17 and DRPLA [2].
Although most patients with SCAs come from families exhibitingrtment of Neurology, Universi-
. Sophias Ave., Athens 11528,
Y license.autosomal dominant (AD) inheritance, occasionally apparently spo-
radic cases can be attributed to a SCA mutation [5].
In the present study we sought to investigate the relative frequen-
cy of the triplet repeat expansion SCAs in a Greek population of famil-
ial and sporadic ataxia patients. To the best of our knowledge, no
information exists to date regarding SCAs in Greece.
2. Methods
A total of 83 Greek patients exhibiting a slowly progressive cere-
bellar ataxia with or without additional neurological features were in-
cluded in the study. They were consecutively referred to the
Neurogenetics Unit of the Department of Neurology, University of
Athens, Eginitio Hospital, for the exclusion of genetic causes of ataxia,
over a period when only the Friedreich expansion was available diag-
nostically in our laboratory. Of the total cohort, 20 were probands
from families exhibiting AD inheritance with affected members in
successive generations. The total number of affected individuals still
alive was 56. Another 7 patients belonged to families with more
than one affected member in a single generation, suggestive of auto-
somal recessive inheritance, but also compatible in certain cases with
dominant inheritance. Fifty six patients were isolated cases of ataxia,
apparently sporadic. Demographic and clinical details of the patient
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MRI, CSF analysis, routine biochemical, haematological and immuno-
logical screens, thyroid function tests, as well as vitamins B12 and E
were performed to exclude known acquired causes of progressive
cerebellar ataxia. Additionally, all patients were tested and found
negative for the triplet expansion causing Friedreich ataxia.
DNA was isolated from peripheral blood leucocytes. Written in-
formed consent to perform molecular genetic studies was obtained
from all patients and the study was approved by the ethics committee
of Eginitio Hospital. DNA was ampliﬁed by PCR using appropriate
primer pairs for ATXN1, ATXN2, ATXN3, CACNA1A, ATXN7, ATXN8/ATX-
N8OS, PP2R2B, TBP and ATN1 according to established protocols. PCR
products were checked on a 4% agarose mini gel and then run on an
ABI3730XL genetic analyzer with a LIZ500 size standard. Fragment
analysis was performed with GeneMapper version 3.7 software. Sta-
tistical analysis was performed on SPSS version 13.0.
3. Results
In total, 4 patients with pathological SCA expansions were found.
They all belonged to the group with clear AD inheritance, comprising
20% of these patients (Table 1). Two patients had SCA1 (10.0% of AD
group), one SCA2 (5.0% of AD group) and one SCA7 (5.0% of AD
group). The remaining patients with AD disease (80%) were negative
for expansions in the loci tested. No pathological expansions were
found in the group with probable recessive or unclear inheritance
pattern. Likewise, no abnormal expansions were detected in the
group with apparently sporadic ataxia. Overall, no patients with
SCA3, SCA6, SCA12, SCA17 or DRPLA were identiﬁed.
Clinical features of patients with pathological expansions are
shown in the Supplementary table. No patient had a pure cerebellar
ataxia. Both SCA1 patients exhibited pyramidal signs in addition to
ataxia, the patient with longer disease duration also exhibiting
ophthalmoplegia, sensory signs and mild cognitive impairment. The
SCA2 patient had slow saccades and hyporeﬂexia. The patient with
the SCA7 expansion had additional retinopathy, expressed clinically
as a dyschromatopsia, optic atrophy and pyramidal signs.
4. Discussion
The present study provides information regarding the frequency
of SCAs in the Greek population. To the best of our knowledge,
there have been no previous reports to date on this subject. Given
the substantial variation in the relative frequency of different SCAs
according to ethnic origin, it is of interest to speciﬁcally investigate
the case of Greece, both from a local diagnostic and a more generalTable 1
Demographic, clinical and genetic characteristics of the patient cohort.
Autosomal
dominant
Other
familial
Sporadic Total
N 20 7 56 83
Sex (F/M) 11/9 3/4 30/26 44/39
Age (yrs) 44.1±12.7 43.9±10.0 41.4
±18.2
42.2
±16.3
Age at onset (yrs) 30.3±13.0 19.7±18.0 27.9
±20.5
27.7
±18.7
Early/late onseta 5/15 2/5 27/29 34/49
SCA1 (%) 2 (10.0) 0 0 2 (2.4)
SCA2 (%) 1 (5.0) 0 0 1 (1.2)
SCA7 (%) 1 (5.0) 0 0 1 (1.2)
SCA3, SCA6, SCA8,
SCA12, SCA17, DRPLA
0 0 0 0
Total SCA positive (%) 4 (20.0) 0 0 4 (4.8)
a Early onset deﬁned as b25 years; SCA: spinocerebellar ataxia; DRPLA: dentatorubral-
pallidoluysian atrophy.epidemiological perspective. Although the absolute number of AD
families studied was low (20), given the estimated prevalence of
ADCAs in European populations (1 to 3/100,000) and taking into con-
sideration the total number of affected individuals (56), this ought to
represent a substantial proportion of Greek patients with SCAs, rang-
ing from around 18 to 55%, based on the population of Greece and the
assumed underlying prevalence [2,6].
Despite the low number of AD families studied, certain general
conclusions may be drawn. SCA3, the commonest SCA worldwide
seems to be rare in Greece [2]. Additionally, SCA6, representing in
many populations around 15% of SCAs, seems also rare [2,4]. These
ﬁndings are to some extent similar to data reported from Italy,
where SCA1 and SCA2 are by far the commonest SCAs in contrast to
SCA3 and SCA6, which are very rare [7]. SCA3 also seems to be rare
in India, where SCA6 is virtually absent [8]. SCA6 is also only rarely
found in Spain and France [9,10]. Regarding the remaining common
SCAs, the relative frequencies detected, 10% for SCA1, 5% for SCA2
and 5% for SCA7 are not substantially different from those observed
in several European and Asian populations [2].
Given results from previously studied populations, we were
expecting to ﬁnd a genetic cause in at least 50% of our AD ataxia
cases [2]. However, only 20% of this group proved to carry one of
the tested expansions. A similarly high proportion of unexplained
AD ataxia pedigrees has been reported from Norway and the UK
[11,12]. It remains to be determined what the underlying genetic
cause in these patients is. Possible founder effects involving any of
the known SCAs that were not tested or other unknown mutations
could partly explain the present ﬁnding.
No SCA triplet expansions were detected in any of the patients
from the probably recessive/ unclear inheritance group or the sporad-
ic group. In the familial group this would be expected if these patients
indeed represented recessive pedigrees. In the case of sporadic
ataxias, previous studies have reported somewhat varying results,
with SCA expansions found in less than 1% of patients in some series
[9,12] and up to 10% in other series [5,13]. Interestingly, SCA6 is the
most common SCA expansion detected in these patients (6–7%). If
therefore the underlying prevalence of SCA6 is very low in the popu-
lation under study, this would be expected to inﬂuence the number of
sporadic cases carrying an expansion. This was the case in the Spanish
population and may also inﬂuence the ﬁndings in Greek patients [9].
Another factor possibly contributing to the absence of SCA expansions
in the sporadic cases was the signiﬁcant proportion of early onset
cases, possibly reﬂecting an unidentiﬁed underlying recessive cause
[14]. Of course, the strictness of inclusion criteria in sporadic cases
could also substantially inﬂuence the results in this group of patients.
In conclusion, the present study provides the ﬁrst data on the fre-
quency of SCAs due to triplet expansions in the Greek population. Pa-
tients with SCA1, SCA2 and SCA7 were identiﬁed, but SCA3 and SCA6
were not found. The genetic cause for the majority of AD pedigrees
remains to be identiﬁed. In sporadic cases no SCA expansions were
found.
Supplementary data to this article can be found online at doi:10.
1016/j.jns.2012.03.019.Conﬂict of interest
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